Nuciferine inhibits osteoclast formation through suppressing glycolysis metabolic programming and ROS production
Wen‐Hui Guo, Guan‐Qi Zhen, Feng Wu, Yun‐Peng Lv, Jing‐Long Yan, Jia‐Ning Zu, Cheng‐Chao Song · 2024
Read Nuciferine inhibits osteoclast formation through suppressing glycolysis metabolic programming and ROS production by Wen‐Hui Guo, Guan‐Qi Zhen, Feng Wu, Yun‐Peng Lv, Jing‐Long Yan, Jia‐Ning Zu, Cheng‐Chao Song (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11618493.txt.
Description
Wen-Hui Guo and co-authors explain how a lotus leaf compound blocks bone-eating cell formation, in a 2024 study. The compound, nuciferine, had already been shown by the team to guard against bone loss. Osteoclasts are the cells that dissolve bone, and their birth needs careful control. The mechanism behind the compound's protection was still unclear.
Mouse cells were coaxed into osteoclasts with and without the compound. At the tested dose, the compound did not harm cell life or growth. Bone-eating cell birth and actual bone chewing both fell sharply. Energy tests showed the cells burned less sugar and breathed more oxygen. Gene and protein checks tied the shift to lower sugar burning and lower reactive oxygen output.
Catalog record
| CREATOR | Wen‐Hui Guo, Guan‐Qi Zhen, Feng Wu, Yun‐Peng Lv, Jing‐Long Yan, Jia‐Ning Zu, Cheng‐Chao Song |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |